Literature DB >> 21370032

Signaling events initiated by kappa opioid receptor activation: quantification and immunocolocalization using phospho-selective KOR, p38 MAPK, and K(IR) 3.1 antibodies.

Julia C Lemos1, Clarisse A Roth, Charles Chavkin.   

Abstract

Psychiatric disorders including anxiety, depression, and addiction are both precipitated and exacerbated by severe or chronic stress exposure. While acutely, stress responses are adaptive, repeated exposure to stress can dysregulate the brain in such a way as to predispose the organism to both physiological and mental illness. Understanding the neuronal chemicals, cell types, and circuits involved in both normal and pathological stress responses are essential in developing new therapeutics for psychiatric diseases. Varying degrees of stressor exposure cause the release of a constellation of chemicals, including neuropeptides such as dynorphin. Neuropeptidergic release can be very difficult to directly measure with adequate spatial and temporal resolution. Moreover, the downstream consequences following release and receptor binding are numerous and also difficult to measure with cellular resolution. Following repeated stressor exposure, dynorphin is released, binds to the kappa opioid receptor (KOR), and causes activation of KOR. Agonist-activated KOR becomes a substrate for G protein receptor kinase (GRK), which phosphorylates the Ser369 residue at the C-terminal tail of the receptor in the first step in the β-Arrestin-dependent desensitization cascade. Through the use of phospho--selective antibodies developed and validated in the laboratory, we have the tools, to assess with fine cellular resolution, the strength of behavioral stimulus required for release, time course of the release, and regional location of release. We have gone on to show that following KOR activation, both ERK 1/2 and p38 MAP kinase phosphorylation are increased through use of commercially available phospho-selective antibodies. Finally, we have identified that one effector of KOR/p38MAP kinase is K(IR) 3.1 and have developed a phospho-selective antibody against the Y12 motif of this channel. Much like KOR and p38 MAP kinase, phosphorylation of this potassium channel increases following repeated stress. The following chapter discusses immunohistochemical and quantification methods used for phospho-selective antibodies used in various brain regions following behavioral manipulations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21370032      PMCID: PMC3727639          DOI: 10.1007/978-1-61779-024-9_11

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  13 in total

Review 1.  Conditioned place preference: what does it add to our preclinical understanding of drug reward?

Authors:  M T Bardo; R A Bevins
Journal:  Psychopharmacology (Berl)       Date:  2000-12       Impact factor: 4.530

2.  Dual MAP kinase pathways mediate opposing forms of long-term plasticity at CA3-CA1 synapses.

Authors:  V Y Bolshakov; L Carboni; M H Cobb; S A Siegelbaum; F Belardetti
Journal:  Nat Neurosci       Date:  2000-11       Impact factor: 24.884

3.  A common ankyrin-G-based mechanism retains KCNQ and NaV channels at electrically active domains of the axon.

Authors:  Zongming Pan; Tingching Kao; Zsolt Horvath; Julia Lemos; Jai-Yoon Sul; Stephen D Cranstoun; Vann Bennett; Steven S Scherer; Edward C Cooper
Journal:  J Neurosci       Date:  2006-03-08       Impact factor: 6.167

4.  Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes.

Authors:  Michael R Bruchas; Tara A Macey; Janet D Lowe; Charles Chavkin
Journal:  J Biol Chem       Date:  2006-04-28       Impact factor: 5.157

5.  Immunocytochemical localization of delta opioid receptors in mouse brain.

Authors:  S B Bausch; T A Patterson; S M Appleyard; C Chavkin
Journal:  J Chem Neuroanat       Date:  1995-03       Impact factor: 3.052

6.  Stress-induced p38 mitogen-activated protein kinase activation mediates kappa-opioid-dependent dysphoria.

Authors:  Michael R Bruchas; Benjamin B Land; Megumi Aita; Mei Xu; Sabiha K Barot; Shuang Li; Charles Chavkin
Journal:  J Neurosci       Date:  2007-10-24       Impact factor: 6.167

7.  Repeated swim stress induces kappa opioid-mediated activation of extracellular signal-regulated kinase 1/2.

Authors:  Michael R Bruchas; Mei Xu; Charles Chavkin
Journal:  Neuroreport       Date:  2008-09-17       Impact factor: 1.837

8.  Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking.

Authors:  Benjamin B Land; Michael R Bruchas; Selena Schattauer; William J Giardino; Megumi Aita; Daniel Messinger; Thomas S Hnasko; Richard D Palmiter; Charles Chavkin
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-28       Impact factor: 11.205

9.  Phosphorylation of a carboxyl-terminal serine within the kappa-opioid receptor produces desensitization and internalization.

Authors:  Jay P McLaughlin; Mei Xu; Ken Mackie; Charles Chavkin
Journal:  J Biol Chem       Date:  2003-06-18       Impact factor: 5.157

10.  N-terminal tyrosine residues within the potassium channel Kir3 modulate GTPase activity of Galphai.

Authors:  Danielle L Ippolito; Paul A Temkin; Sherri L Rogalski; Charles Chavkin
Journal:  J Biol Chem       Date:  2002-06-24       Impact factor: 5.157

View more
  6 in total

1.  Salvinorin A pretreatment preserves cerebrovascular autoregulation after brain hypoxic/ischemic injury via extracellular signal-regulated kinase/mitogen-activated protein kinase in piglets.

Authors:  Diansan Su; John Riley; William M Armstead; Renyu Liu
Journal:  Anesth Analg       Date:  2011-11-10       Impact factor: 5.108

2.  Hippocampal long-term potentiation is disrupted during expression and extinction but is restored after reinstatement of morphine place preference.

Authors:  George S Portugal; Ream Al-Hasani; Amanda K Fakira; Jose L Gonzalez-Romero; Zare Melyan; Jordan G McCall; Michael R Bruchas; Jose A Morón
Journal:  J Neurosci       Date:  2014-01-08       Impact factor: 6.167

3.  Effect of chronic alcohol vapor exposure on reinstatement of alcohol seeking induced by U50,488.

Authors:  Douglas Funk; Kathleen Coen; Sahar Tamadon; A D Lê
Journal:  Neuropharmacology       Date:  2019-01-16       Impact factor: 5.250

Review 4.  Neuropeptide System Regulation of Prefrontal Cortex Circuitry: Implications for Neuropsychiatric Disorders.

Authors:  Sanne M Casello; Rodolfo J Flores; Hector E Yarur; Huikun Wang; Monique Awanyai; Miguel A Arenivar; Rosario B Jaime-Lara; Hector Bravo-Rivera; Hugo A Tejeda
Journal:  Front Neural Circuits       Date:  2022-06-21       Impact factor: 3.342

5.  Locus coeruleus kappa-opioid receptors modulate reinstatement of cocaine place preference through a noradrenergic mechanism.

Authors:  Ream Al-Hasani; Jordan G McCall; Audra M Foshage; Michael R Bruchas
Journal:  Neuropsychopharmacology       Date:  2013-06-21       Impact factor: 7.853

6.  Optogenetic stimulation of dynorphinergic neurons within the dorsal raphe activate kappa opioid receptors in the ventral tegmental area and ablation of dorsal raphe prodynorphin or kappa receptors in dopamine neurons blocks stress potentiation of cocaine reward.

Authors:  Antony D Abraham; Sanne M Casello; Benjamin B Land; Charles Chavkin
Journal:  Addict Neurosci       Date:  2022-01-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.